|
|
1#
Big Middle
Small posted on Apr 18, 2008 20:47 Only show author

Expert Opinion on Pharmacotherapy, 2008 February, Volume 9, Number 6
Free Content:Editorial
$ N+ d# B7 d; n# ]
3 A; ~6 h/ Q, ~6 k; S7 wThe failure of torcetrapib: is there a case for independent preclinical and clinical testing?
1 ?- E( U) p7 b. V# b6 W7 MSheila A Doggrell6 O D1 |) A8 e6 C1 V
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 875-878.% e' ~5 \' U& E+ \- T
' G! D; D4 B B0 ^ O1 NOriginal Research+ z% @0 I5 X e0 h) a* e% U
0 g' o$ B& o# @# @1 ]5 _+ D
Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft
3 h/ ?' |& J5 w O6 bIrmgard Neumann, Heinz Fuhrmann, Marina Kanzler, I-Fei Fang, Adelheid Jaeger, Helmut Graf, Peter Bayer, Josef Kovarik4 ^% M- A# @3 i0 ~# S g
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 879-886.
- O" j+ E* i$ \
& _, c- u1 d9 YReviews
) Z$ J! c) B' a# H- F ! l' J7 \1 S# q0 a; M
Neuroprotectants in stroke therapy
3 o& y* X) j2 S3 l& r& hK Jeyaseelan, KY Lim, A Armugam
* F+ |: X- y9 r9 Y% F; WExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 887-900.+ G9 W G- I! z; z
" p+ V; o; Z- l# f$ Y0 J: P4 f, yHaemorrhagic shock therapy
) G- D" @, Q. D6 K9 ~! B$ @! [Devashish J Anjaria, Alicia M Mohr, Edwin A Deitch6 o) H, Y9 A* T1 h8 Y g+ G# N$ ~# V
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 901-911.
' M w5 f2 B# ` M9 x 6 l$ ~7 Z) V1 c$ t }
Pharmacotherapy of atrial fibrillation: an old option with new possibilities/ k: h/ ?3 o4 g) w6 ]$ f
Sabine Janko, Uwe Dorwarth, Ellen Hoffmann$ W) F# s) G. u/ [: A6 R
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 913-925.! {& d+ j; i" w8 s9 {1 _ j
( @7 U. a, e7 L3 D
Fungicidal versus Fungistatic: what's in a word?
! z' k0 R! p, X7 BJames S Lewis II, John R Graybill2 E4 e9 E( Z g4 p! u" E
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 927-935.
4 d; v$ d9 L) x& X* D* `2 {' ` " J/ V- {' p7 ]" Q+ u# S
Pharmacotherapy of bone metastases in breast cancer patients
- X3 @. M$ V( R# @4 X! D/ h2 BBianca Petrut, Christine Simmons, Reuben Broom, Mateya Trinkaus, Mark Clemons, J0 g6 I# ]7 w
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 937-945.: \) a) k5 F7 b. m
% l; f3 m, B* L% n* t* r% }Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism
( j$ q& p, w( ]! c" T3 WMario Cozzolino, Diego Brancaccio
c% ?2 u! X+ EExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 947-954.3 m l- f; v0 O2 ^
! k" a$ H% _/ T" x) mPharmacotherapy of acne
' ?% A/ K( w0 ~6 x* I I/ n6 ?% mKlaus Degitz, Falk Ochsendorf
4 l% g" e5 y" m- W9 w3 I- @8 AExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 955-971.
+ q A7 i6 b% V v: G4 ~ 7 U3 i$ g2 e" O A0 v9 o0 O, Y" D
Therapeutic management of psychodermatological disorders' q& j; i; A( _7 J: f
Philip D Shenefelt
4 ?# P/ ]1 _& U8 H( A2 Z4 O0 WExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 973-985.. b, a! a: I, @, f2 J- `
7 O( ]! ]; u1 ` P+ B3 y, O0 `2 {Pharmacoeconomic Evaluation
- o! J. E( M& r2 M- } r0 ? , [9 G! F) j& u- Z# C \ S: s
Pharmacoeconomics of linezolid
' V- ~+ M4 r4 G1 l4 WSantiago Grau, Carlos Rubio-Terrés
* {+ H4 T0 m! D! i& `4 ~. h, Q qExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 987-1000.! |9 ^2 ~6 B4 y6 R9 a
. o. A4 N- D g3 n. S
Drug Evaluations
; j3 _# N4 ~0 Q3 v, M P l* D% l5 |7 C
A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future& D F+ ?0 Q- O0 S' s
Lisa K Mannix
& k' ~. p% |! ]Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1001-1011.( W# m4 Z/ A0 }/ M X
# T' M2 p8 q8 l+ SZoledronic acid for cancer therapy-induced and postmenopausal bone loss
7 U2 N* e- K6 kAdam M Brufsky. A6 F* {8 V. M {- V" G
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1013-1028.
' h4 u5 r- h+ Q& }; @ a; P ! Y" B8 W% P' |" m. [$ T5 X3 ^
Homoharringtonine for the treatment of chronic myelogenous leukemia! y2 i& [" Z& u) z6 c1 q
Alfonso Quintás-Cardama, Jorge Cortes/ m( [) T9 n9 p+ B
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1029-1037.. Q6 M$ z6 c* ]5 J* r- a
1 O, C7 H% V0 C, q, zTibolone: the way to beat many a postmenopausal ailments6 v9 A9 G O& X7 M# P* O$ Y# n! @
Gordana Lazovic, Ubavka Radivojevic, Jelena Marinkovic& L3 b" E* m" D+ M0 |
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1039-1047.& e" w6 ^( Z* L9 b- R1 J8 {
' @+ t5 z( o J! h% B6 B4 s. {
MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis
; C, ?3 P/ _7 WMary Y Hu, Mark A Peppercorn
- ?* X8 b2 d! A( Y8 O, p4 X! l1 EExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1049-1058.) q1 I& \+ q# t2 l6 X4 W8 Y
$ C) N2 F( f* C! @! N# d8 P R# v
Travoprost/timolol fixed combination
9 k! K$ S, ]/ RMichael Herceg, Robert Noecker5 v3 N/ B5 R0 x/ Q2 \3 K
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1059-1065. * B/ [+ [- F; v2 R/ P% q9 @
the hidden contents only visible for repliers
/ H; L7 [. z) n& B4 u4 i$ `( V+ O6 m
[ Last edited by blega at Apr 18, 2008 20:52 ]
|